Chuen Lam

Title: Innovations in Refractive Disorder Treatment by Chuen Lam

Introduction

Chuen Lam is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of ophthalmology, particularly in the treatment of refractive disorders. His innovative approach focuses on targeting the peroxisome proliferator-activated receptor (PPAR) signaling pathway.

Latest Patents

Chuen Lam holds 1 patent for his work titled "Treating refractive disorders by targeting peroxisome proliferator-activated receptor (PPAR) signaling pathway." This patent describes a pharmacologic treatment for refractive disorders, specifically myopia and hyperopia. The treatment utilizes a PPARγ agonist that does not bind to PPARα. His research demonstrates that the PPARγ agonist can modulate ocular growth through therapeutic intervention at the protein level of the PPAR signaling pathway. The effectiveness of this agonist has been validated through experiments using a lens-induced myopia (LIM) animal model. Furthermore, it has been shown that the pharmacological reduction of myopic eye growth can be achieved with a dosage effect through the administration of the PPARγ agonist.

Career Highlights

Chuen Lam has worked with esteemed organizations such as the Centre for Eye and Vision Research Limited and The Hong Kong Polytechnic University. His career reflects a strong commitment to advancing the understanding and treatment of eye disorders.

Collaborations

Chuen Lam has collaborated with notable colleagues, including Ying Hon Sze and Yan Yin Tse. Their combined efforts contribute to the ongoing research and development in the field of vision science.

Conclusion

Chuen Lam's innovative work in treating refractive disorders through the PPAR signaling pathway represents a significant advancement in ophthalmology. His contributions are paving the way for new therapeutic options for individuals affected by myopia and hyperopia.